TREATMENT OF THE IDIOPATHIC NEPHROTIC SYNDROME SPECTRUM DISEASES USING BASILIXIMAB

摘要

Methods for treating Idiopathic Nephrotic Syndrome Spectrum (INSS) diseases using antibodies to the IL-2 receptor (anti-IL-2r antibodies) of T cells, such as basiliximab are described. The methods may be used for treating the broad spectrum of INSS diseases in both children and adults.